Region: France

French SPC rulings give first signs of Royalty Pharma’s impact

Paris Court of Appeal turns down three appeals over supplementary protection certificate rejections

12 April 2021

Record French damages award is a good sign for pharma patentees

Recent decision to award Eli Lilly a preliminary injunction and damages in case against a generic company demonstrates an increasingly pro-rights holder approach on the part of a key French court

08 February 2021

French Court of Appeal SPC decision raises validity concerns

Merck IP right fails test in latest Article 3(a) judgment in case that may make France an even more attractive venue for nullity actions

26 October 2020

Dividing UPC life sciences division would be a mistake, warns Bracco IP strategy chief

Splitting what should have been the London court’s competencies between Paris and Munich must only be a temporary fix, says Francesco Macchetta

06 October 2020

Record damages awarded by Paris court in pemetrexed patent battle

France becoming more friendly to pharma IP, experts suggest, following decision over blockbuster cancer treatment Alimta

24 September 2020

EPO plant patent decision imperils businesses like ours, says Bayer’s head of IP

Joerg Thomaier tells IAM that the Enlarged Board of Appeal got it wrong in a recent controversial ruling, but says the case is now closed and companies have to learn to live with it

22 September 2020

Sanofi eyes more M&A as deals drive increase in IP portfolio quality

The French pharmaceutical’s holdings have shrunk over recent years and application output is at a low, but recent acquisitions have provided a boost while a patent revamp is around the corner

28 August 2020

Revealed – the US law firms that receive the most patent filing work from abroad

An in-depth look at the American patent lawyers most sought after by foreign firms when it comes to USPTO applications

21 August 2020

How compulsory licensing regimes in key European jurisdictions might respond to a covid-19 cure

Experts in France, Germany, Italy, Spain and the UK explain how their jurisdictions are set up to apply march-in rights should viable coronavirus treatments emerge

14 August 2020

Intellectual property on demand

Leading law firms consider how different governments might apply compulsory licensing in response to potential covid-19 breakthroughs

12 August 2020

Unlock unlimited access to all IAM content